Stable pulmonary function after haploidentical stem cell transplantation with post-transplant cyclophosphamide: a single center experience

References

• Gooley TA, Chien JW, Pergam SA, et al. Reduced mortality after allogeneic hematopoietic-cell transplantation. N Engl J Med. 2010;363(22):2091–2101.
   PubMed Web of Science ®Google Scholar
• Passweg JR, Baldomero H, Chabannon C, for the European Society for Blood and Marrow Transplantation (EBMT), et al. The EBMT activity survey on hematopoietic-cell transplantation and cellular therapy 2018: CAR-T’s come into focus. Bone Marrow Transplant. 2020;55(8):1604–1613.
   PubMed Web of Science ®Google Scholar
• Yen KT, Lee AS, Krowka MJ, et al. Pulmonary complications in bone marrow transplantation: a practical approach to diagnosis and treatment. Clin Chest Med. 2004;25(1):189–201.
   PubMed Web of Science ®Google Scholar
• Parimon T, Madtes DK, Au DH, et al. Pretransplant lung function, respiratory failure, and mortality after stem cell transplantation. Am J Respir Crit Care Med. 2005;172(3):384–390.
   PubMed Web of Science ®Google Scholar
• Badier M, Guillot C, Delpierre S, et al. Pulmonary function changes 100 days and one year after bone marrow transplantation. Bone Marrow Transplant. 1993;12(5):457–461.
   PubMed Web of Science ®Google Scholar
• Dirou S, Malard F, Chambellan A, et al. Stable long-term pulmonary function after fludarabine, antithymocyte globulin and i.v. BU for reduced-intensity conditioning allogeneic SCT. Bone Marrow Transplant. 2014;49(5):622–627.
   PubMed Web of Science ®Google Scholar
• Piñana JL, Martino R, Barba P, et al. Pulmonary function testing prior to reduced intensity conditioning allogeneic stem cell transplantation in an unselected patient cohort predicts posttransplantation pulmonary complications and outcome. Am J Hematol. 2012;87(1):9–14.
   PubMed Web of Science ®Google Scholar
• Sagou K, Ukai S, Adachi Y, et al. Decline of forced expiratory volume in 1 s after allogeneic hematopoietic cell transplantation is a good indicator for pulmonary damage and is associated with busulfan use. Int J Hematol. 2019;109(3):299–308.
   PubMed Web of Science ®Google Scholar
• Lee J-H, Choi S-J, Lee J-H, et al. Severe metabolic abnormalities after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2005;35(1):63–69.
   PubMed Web of Science ®Google Scholar
• Ramirez-Sarmiento A, Orozco-Levi M, Walter EC, et al. Influence of pretransplantation restrictive lung disease on allogeneic hematopoietic cell transplantation outcomes. *Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant. 2010;16(2):199–206.
   PubMedGoogle Scholar
• Ahn JH, Jo K-W, Song JW, et al. Prognostic role of FEV1 for survival in bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation. Clin Transplant. 2015;29(12):1133–1139.
   PubMed Web of Science ®Google Scholar
• Srinivasan A, Sunkara A, Mitchell W, et al. Recovery of pulmonary function after allogeneic hematopoietic cell transplantation in children is associated with improved survival. Biol Blood Marrow Transplant. 2017;23(12):2102–2109.
   PubMed Web of Science ®Google Scholar
• Bacigalupo A, Ballen K, Rizzo D, et al. Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transplant. 2009;15(12):1628–1633.
   PubMed Web of Science ®Google Scholar
• Armand P, Kim HT, Logan BR, et al. Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation. Blood. 2014;123(23):3664–3671.
   PubMed Web of Science ®Google Scholar
• Lucena CM, Torres A, Rovira M, et al. Pulmonary complications in hematopoietic SCT: a prospective study. Bone Marrow Transplant. 2014;49(10):1293–1299.
   PubMed Web of Science ®Google Scholar
• Sharma S, Nadrous HF, Peters SG, et al. Pulmonary complications in adult blood and marrow transplant recipients: autopsy findings. Chest. 2005;128(3):1385–1392.
   PubMed Web of Science ®Google Scholar
• Ditschkowski M, Elmaagacli AH, Trenschel R, et al. T-cell depletion prevents from bronchiolitis obliterans and bronchiolitis obliterans with organizing pneumonia after allogeneic hematopoietic stem cell transplantation with related donors. Haematologica. 2007;92(4):558–561.
   PubMed Web of Science ®Google Scholar
• Walter EC, Orozco-Levi M, Ramirez-Sarmiento A, et al. Lung function and long-term complications after allogeneic hematopoietic cell transplant. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant. 2010;16(1):53–61.
   PubMed Web of Science ®Google Scholar
• Bacigalupo A, Lamparelli T, Barisione G, Gruppo Italiano Trapianti Midollo Osseo (GITMO), et al. Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation. Biol Blood Marrow Transplant. 2006;12(5):560–565.
   PubMed Web of Science ®Google Scholar
• Slade M, Goldsmith S, Romee R, et al. Epidemiology of infections following haploidentical peripheral blood hematopoietic cell transplantation. Transpl Infect Dis Off J Transplant Soc. 2017;19:e12629.
   PubMed Web of Science ®Google Scholar
• Mohty R, Brissot E, Battipaglia G, et al. Infectious complications after post-transplantation cyclophosphamide and anti-thymocyte globulin-based haploidentical stem cell transplantation. Br J Haematol. 2019;187(3):e64–e68.
   PubMed Web of Science ®Google Scholar
• Chien JW, Maris MB, Sandmaier BM, et al. Comparison of lung function after myeloablative and 2 Gy of total body irradiation-based regimens for hematopoietic stem cell transplantation. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant. 2005;11(4):288–296.
   PubMed Web of Science ®Google Scholar
• White AC, Terrin N, Miller KB, et al. Impaired respiratory and skeletal muscle strength in patients prior to hematopoietic stem-cell transplantation. Chest. 2005;128(1):145–152.
   PubMed Web of Science ®Google Scholar
• Savani BN, Montero A, Srinivasan R, et al. Chronic GVHD and pretransplantation abnormalities in pulmonary function are the main determinants predicting worsening pulmonary function in long-term survivors after stem cell transplantation. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant. 2006;12(12):1261–1269.
   PubMed Web of Science ®Google Scholar
• Sorror ML, Maris MB, Storb R, et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood. 2005;106(8):2912–2919.
   PubMed Web of Science ®Google Scholar
• Crawford SW, Fisher L. Predictive value of pulmonary function tests before marrow transplantation. Chest. 1992;101(5):1257–1264.
   PubMed Web of Science ®Google Scholar
• Matute-Bello G, McDonald GD, Hinds MS, et al. Association of pulmonary function testing abnormalities and severe veno-occlusive disease of the liver after marrow transplantation. Bone Marrow Transplant. 1998;21(11):1125–1130.
   PubMed Web of Science ®Google Scholar
• Chien JW, Sullivan KM. Carbon monoxide diffusion capacity: how low can you go for hematopoietic cell transplantation eligibility? Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant. 2009;15(4):447–453.
   PubMed Web of Science ®Google Scholar
• Vieira AG, Funke VAM, Nunes EC, et al. Bronchiolitis obliterans in patients undergoing allogeneic hematopoietic SCT. Bone Marrow Transplant. 2014;49(6):812–817.
   PubMed Web of Science ®Google Scholar
• Penna GB, da Silva TC, Aparecida Paz A, et al. Functional capacity, pulmonary function, and quality of life in hematopoietic stem cell transplantation survivors. Support. Care cancer Off. J. Multinatl. Assoc. Supportive Care in Cancer 2021(29):4015–4021.
   PubMedGoogle Scholar